10th week of 2020 patent applcation highlights part 9 |
Patent application number | Title | Published |
20200069573 | Topical Supplement Composition and Method of Use | 2020-03-05 |
20200069574 | THERAPEUTIC METHODS INVOLVING GASTROINTESTINAL IMPLANTS | 2020-03-05 |
20200069575 | OPHTHALMIC FORMULATIONS, PROCESS FOR PREPARING THE SAME AND METHOD FOR ADMINISTERING THE SAME | 2020-03-05 |
20200069576 | COMPOSITIONS CONTAINING ALPHA-2-ADRENERGIC AGONIST COMPONENTS | 2020-03-05 |
20200069577 | OPHTHALMIC FORMULATIONS, PROCESS FOR PREPARING THE SAME AND METHOD FOR ADMINISTERING THE SAME | 2020-03-05 |
20200069578 | BIODEGRADABLE ALPHA-2 AGONIST POLYMERIC IMPLANTS AND THERAPEUTIC USES THEREOF | 2020-03-05 |
20200069579 | DISPERSIBLE COMPOSITIONS | 2020-03-05 |
20200069580 | ICE POP MEDICAMENT DELIVERY SYSTEM AND METHOD | 2020-03-05 |
20200069581 | CANNABINOID AND ANESTHETIC GUM AND LOZENGE COMPOSITIONS AND METHODS | 2020-03-05 |
20200069582 | INHALABLE HEMODYNAMIC AGENTS AND METHODS OF USING THE SAME | 2020-03-05 |
20200069583 | IN SITU PHASE CHANGE GEL SUSTAINED-RELEASE SYSTEM FOR SMALL MOLECULE DRUG AND PREPARATION METHOD THEREOF | 2020-03-05 |
20200069584 | COMPOSITION AND METHOD FOR VANCOMYCIN ORAL LIQUID | 2020-03-05 |
20200069585 | COMPOSITIONS FOR UPREGULATING DEFENSIN EXPRESSION | 2020-03-05 |
20200069586 | Stabilizing Camptothecin Pharmaceutical Compositions | 2020-03-05 |
20200069587 | MULTIVALENT DELIVERY OF IMMUNE MODULATORS BY LIPOSOMAL SPHERICAL NUCLEIC ACIDS FOR PROPHYLACTIC OR THERAPEUTIC APPLICATIONS | 2020-03-05 |
20200069588 | PROCESS FOR MANUFACTURING POROUS SILICA PARTICLES LOADED WITH AT LEAST ONE BIOACTIVE COMPOUND ADAPTED FOR LUNG, NASAL, SUBLINGUAL, AND/OR PHARYNGEAL DELIVERY | 2020-03-05 |
20200069589 | MICROPARTICLES AND NANOPARTICLES HAVING NEGATIVE SURFACE CHARGES | 2020-03-05 |
20200069590 | APPARATUS AND METHOD FOR CRYOGRANULATING A PHARMACEUTICAL COMPOSITION | 2020-03-05 |
20200069591 | PHARMACEUTICAL PREPARATION AND METHOD FOR ITS MANUFACTURE | 2020-03-05 |
20200069592 | HSP90 INHIBITOR ORAL FORMULATIONS AND RELATED METHODS | 2020-03-05 |
20200069593 | Immediate Release Tablet of a Benzothiophene Compound | 2020-03-05 |
20200069594 | HYBRID EXOSOMAL-POLYMERIC (HEXPO) NANO-PLATFORM FOR DELIVERY OF RNAI THERAPEUTICS | 2020-03-05 |
20200069595 | PHARMACEUTICAL FORMULATION AND SYSTEM AND METHOD FOR DELIVERY | 2020-03-05 |
20200069596 | VACCINE DELIVERY SYSTEMS USING YEAST CELL WALL PARTICLES | 2020-03-05 |
20200069597 | TIMED, PULSATILE RELEASE SYSTEMS | 2020-03-05 |
20200069598 | CHOLESTOSOME VESICLES FOR INCORPORATION OF MOLECULES INTO CHYLOMICRONS | 2020-03-05 |
20200069599 | STABILIZED FORMULATIONS OF LIPID NANOPARTICLES | 2020-03-05 |
20200069600 | DELIVERY OF DRUG NANOPARTICLES AND METHODS OF USE THEREOF | 2020-03-05 |
20200069601 | METHOD FOR PREPARING BIOFILM-COATED DRUG NANOCRYSTAL AND USE THEREOF | 2020-03-05 |
20200069602 | CHROMATOGRAPHIC MEDIA FOR STORAGE AND DELIVERY OF THERAPEUTIC BIOLOGICS AND SMALL MOLECULES | 2020-03-05 |
20200069603 | Patch | 2020-03-05 |
20200069604 | CANNABINOID AND ANESTHETIC COMPOSITIONS AND METHODS | 2020-03-05 |
20200069605 | CANNABINOID AND MENTHOL COMPOSITIONS AND METHODS | 2020-03-05 |
20200069606 | VETERINARY CANNABINOID AND MENTHOL COMPOSITIONS AND METHODS | 2020-03-05 |
20200069607 | MOUTHWASH FOR TREATING ORAL CANCERS | 2020-03-05 |
20200069608 | USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSY | 2020-03-05 |
20200069609 | METHOD FOR COVALENT BOND MODIFYING MAMMALIAN ATG8 HOMOLOGUE | 2020-03-05 |
20200069610 | METHOD AND COMPOSITION FOR DECREASING THE PSYCHOTOMIMETIC SIDE EFFECT AND ADDICTIVE DISORDER OF KETAMINE | 2020-03-05 |
20200069611 | SPHINGOSINE KINASE TYPE 1 INHIBITORS AND USES THEREOF | 2020-03-05 |
20200069612 | Pharmaceutical Composition Of S-Ketamine Hydrochloride | 2020-03-05 |
20200069613 | METHOD AND PHARMACEUTICAL COMPOSITION FOR TREATING DEPRESSION | 2020-03-05 |
20200069614 | AMANTADINE COMPOSITIONS, PREPARATIONS THEREOF, AND METHODS OF USE | 2020-03-05 |
20200069615 | METHODS AND MATERIALS FOR TREATING CYTOKINE RELEASE SYNDROME | 2020-03-05 |
20200069616 | BETA-ALETHINE, IMMUNE MODULATORS, AND USES THEREOF | 2020-03-05 |
20200069617 | USE OF N-ACETYLCYSTEINE AMIDE IN THE TREATMENT OF ACETAMINOPHEN OVERDOSE | 2020-03-05 |
20200069618 | COMPOSITIONS HAVING AN AGENT AND AN ENHANCER THEREOF, METHODS OF USE, AND DELIVERY SYSTEMS | 2020-03-05 |
20200069619 | PHARMACEUTICAL COMPOSITION | 2020-03-05 |
20200069620 | COMPOSITION AND METHOD FOR MUSCLE REPAIR AND REGENERATION | 2020-03-05 |
20200069621 | Glutarate Compounds for Treating Ischemia-Reperfusion Injuries | 2020-03-05 |
20200069622 | IMMUNOMODULATORY AND DIFFERENTIATING FUNCTION SELECTIVE RETINOID AND REXINOID COMPOUNDS IN COMBINATION WITH IMMUNE MODULATORS FOR CANCER IMMUNOTHERAPY | 2020-03-05 |
20200069623 | CILASTATIN FOR USE IN THE TREATMENT OF SEPSIS | 2020-03-05 |
20200069624 | METHODS OF NORMALIZING AMINO ACID METABOLISM | 2020-03-05 |
20200069625 | COMPOSITION FOR IMPROVING VASCULAR ENDOTHELIAL FUNCTION | 2020-03-05 |
20200069626 | METHODS OF TREATING NON-ALCOHOLIC STEATOHEPATITIS AND NON-ALCOHOLIC FATTY LIVER DISEASE WITH 15-HEPE | 2020-03-05 |
20200069627 | PHARMACEUTICAL COMPOSITIONS COMPRISING DGLA AND USE OF SAME | 2020-03-05 |
20200069628 | Methods and Compositions for Preventing and Treating Auditory Dysfunctions | 2020-03-05 |
20200069629 | PHEROMONE COMPOSITIONS AND USES THEREOF | 2020-03-05 |
20200069631 | SOLID COMPOSITIONS OF TRIGLYCERIDES AND USES THEREOF | 2020-03-05 |
20200069632 | METHODS OF REDUCING THE RISK OF A CARDIOVASCULAR EVENT IN A SUBJECT ON STATIN THERAPY | 2020-03-05 |
20200069633 | LEONURINE CRYSTAL AND USE THEREOF IN PREPARATION OF INSULIN SENSITIZER, HYPOGLYCEMIC DRUG AND LIPID-LOWERING DRUG | 2020-03-05 |
20200069634 | METHOD FOR TREATING INFECTIOUS DISEASES WITH ISOTHIOCYANATE FUNCTIONAL COMPOUNDS | 2020-03-05 |
20200069635 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING LIVER CANCER, COMPRISING TETRAARSENIC HEXOXIDE CRYSTALLINE POLYMORPH | 2020-03-05 |
20200069636 | PROCESS FOR PREPARATION OF CO2 EXTRACT OF AZADIRACHTA INDICA AND HERBAL COMPOSITIONS THEREOF FOR TREATMENT OF CANCERS | 2020-03-05 |
20200069637 | NOVEL SALTS OF 3-[(DIMETHYLAMINO)METHYL]-N-{2-[4-(HYDROXYCARBAMOYL) PHENOXY]ETHYLI-1-BENZOFURAN-2-CARBOXAMIDE, RELATED CRYSTALLINE FORMS, METHOD FOR PREPARING THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | 2020-03-05 |
20200069638 | CANNABINOID AND MENTHOL GUM AND LOZENGE COMPOSITIONS AND METHODS | 2020-03-05 |
20200069639 | CANNABINOID, MENTHOL AND CAFFEINE DISSOLVABLE FILM COMPOSITIONS, DEVICES AND METHODS | 2020-03-05 |
20200069640 | COMPOSITION FOR BKCA CHANNEL ACTIVATION | 2020-03-05 |
20200069641 | METHODS AND COMPOSITIONS FOR REDUCING OR ELIMINATING SYMPTOMS OF WITHDRAWAL FROM DRUGS AND ALCOHOL | 2020-03-05 |
20200069642 | COMPOUNDS AND METHODS FOR THE TREATMENT OF MICROBIAL INFECTIONS | 2020-03-05 |
20200069643 | PYRROLOPYRROLE COMPOSITIONS AS PYRUVATE KINASE (PKR) ACTIVATORS | 2020-03-05 |
20200069644 | NOVEL USE OF A FORMYL PEPTIDE RECEPTOR 2/ LIPOXIN A4 RECEPTOR (FPR2/ALX) AGONIST FOR TREATMENT OF HEART FAILURE | 2020-03-05 |
20200069645 | Use Of Carbamate Compound For Prevention, Alleviation Or Treatment Of Pruritus | 2020-03-05 |
20200069646 | INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE | 2020-03-05 |
20200069647 | RelA Inhibitors for Biofilm Disruption | 2020-03-05 |
20200069648 | HALOALLYLAMINE PYRAZOLE DERIVATIVE INHIBITORS OF LYSYL OXIDASES AND USES THEREOF | 2020-03-05 |
20200069649 | TOPICAL PHARMACEUTICAL COMPOSITION CONTAINING PHENYTOIN AND A (CO -) ANALGESIC FOR THE TREATMENT OF CHRONIC PAIN | 2020-03-05 |
20200069650 | DEXMEDETOMIDINE OR MEDETOMIDINE FOR USE IN TREATING SEPARATION ANXIETY IN DOGS | 2020-03-05 |
20200069651 | COMPOSITIONS AND METHODS FOR TREATING PRESBYOPIA, MILD HYPEROPIA, AND IRREGULAR ASTIGMATISM | 2020-03-05 |
20200069652 | USES OF BENZIMIDAZOLE DERIVATIVE FOR NOCTURNAL ACID BREAKTHROUGH | 2020-03-05 |
20200069653 | METHOD OF TREATMENT OF CNS DISORDERS | 2020-03-05 |
20200069654 | COMPOSITIONS AND METHODS OF RIT1 INHIBITION | 2020-03-05 |
20200069655 | PHARMACEUTICAL COMBINATION COMPRISING PONESIMOD | 2020-03-05 |
20200069656 | Methods of Using Substituted Pyrazole and Pyrazole Compounds and for Treatment of Hyperproliferative Diseases | 2020-03-05 |
20200069657 | KRAS G12C INHIBITORS AND METHODS OF USING THE SAME | 2020-03-05 |
20200069658 | COMBINATION THERAPY FOR PULMONARY HYPERTENSION | 2020-03-05 |
20200069659 | METHODS OF ADMINISTERING IMMUNOSUPPRESSANTS HAVING A SPECIFIED PHARMACODYNAMIC EFFECTIVE LIFE AND THERAPEUTIC MACROMOLECULES FOR THE INDUCTION OF IMMUNE TOLERANCE | 2020-03-05 |
20200069660 | METHODS COMPRISING DOSING COMBINATIONS FOR REDUCING UNDESIRED HUMORAL IMMUNE RESPONSES | 2020-03-05 |
20200069661 | SIROLIMUS CONTAINING COMPOSITIONS | 2020-03-05 |
20200069662 | ANTIFIBROTIC COMPOUNDS AND USES THEREOF | 2020-03-05 |
20200069663 | HETEROAROMATIC COMPOUNDS AS VANIN INHIBITORS | 2020-03-05 |
20200069664 | METHODS FOR TREATING INFECTION | 2020-03-05 |
20200069665 | METHODS OF TREATING HYPERSENSITIVE COUGH OR ITCHING USING ION CHANNEL INHIBITORY COMPOUNDS | 2020-03-05 |
20200069666 | COMBINATION OF A PD-1 ANTAGONIST AND A RAF INHIBITOR FOR TREATING CANCER | 2020-03-05 |
20200069667 | METHODS FOR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2020-03-05 |
20200069668 | Therapeutic Combinations of an IRAK4 Inhibitor and a BTK Inhibitor | 2020-03-05 |
20200069669 | INHIBITION OF SMARCA2 FOR TREATMENT OF CANCER | 2020-03-05 |
20200069670 | DOSAGE REGIMEN FOR AN ALPHA-ISOFORM SELECTIVE PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR | 2020-03-05 |
20200069671 | 3-(1H-PYRAZOL-4-YL)PYRIDINE ALLOSTERIC MODULATORS OF THE M4 MUSCARINIC ACETYLCHOLINE RECEPTOR | 2020-03-05 |
20200069672 | METHODS OF USING A PHENOXYPROPYLAMINE COMPOUND TO TREAT PAIN | 2020-03-05 |
20200069673 | COMBINATION THERAPY USING C-C CHEMOKINE RECEPTOR 4 (CCR4) ANTAGONISTS AND ONE OR MORE IMMUNE CHECKPOINT INHIBITORS | 2020-03-05 |